Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	3.04e-06	37	123	5	GO:0140658
GeneOntologyMolecularFunction	X11-like protein binding	CLSTN2 CLSTN1	1.12e-04	3	123	2	GO:0042988
GeneOntologyMolecularFunction	ATP-dependent activity, acting on DNA	SETX CHD2 CHD3 CHD4 SMARCA2 SMARCA4	1.36e-04	127	123	6	GO:0008094
GeneOntologyMolecularFunction	catalytic activity, acting on DNA	SETX POLG CHD2 CHD3 CHD4 REV3L SMARCA2 SMARCA4	2.22e-04	262	123	8	GO:0140097
GeneOntologyMolecularFunction	neuroligin family protein binding	NRXN3 NRXN2	3.72e-04	5	123	2	GO:0097109
GeneOntologyMolecularFunction	helicase activity	SETX CHD2 CHD3 CHD4 SMARCA2 SMARCA4	4.43e-04	158	123	6	GO:0004386
Domain	SNF2_N	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	1.84e-06	32	121	5	IPR000330
Domain	SNF2_N	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	1.84e-06	32	121	5	PF00176
Domain	-	NBEAL1 CLSTN2 CLSTN1 THBS1 NRXN3 NRXN2	3.55e-05	95	121	6	2.60.120.200
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	4.16e-05	2	121	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	4.16e-05	2	121	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	4.16e-05	2	121	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	4.16e-05	2	121	2	PS51666
Domain	SnAC	SMARCA2 SMARCA4	4.16e-05	2	121	2	SM01314
Domain	SnAC	SMARCA2 SMARCA4	4.16e-05	2	121	2	IPR029295
Domain	QLQ	SMARCA2 SMARCA4	4.16e-05	2	121	2	PF08880
Domain	Calsyntenin	CLSTN2 CLSTN1	1.24e-04	3	121	2	IPR026914
Domain	CHD_N	CHD3 CHD4	1.24e-04	3	121	2	IPR012958
Domain	CHD_C2	CHD3 CHD4	1.24e-04	3	121	2	IPR012957
Domain	CHDCT2	CHD3 CHD4	1.24e-04	3	121	2	PF08074
Domain	CHDNT	CHD3 CHD4	1.24e-04	3	121	2	PF08073
Domain	DUF1086	CHD3 CHD4	1.24e-04	3	121	2	IPR009462
Domain	DUF1087	CHD3 CHD4	1.24e-04	3	121	2	IPR009463
Domain	DUF1087	CHD3 CHD4	1.24e-04	3	121	2	PF06465
Domain	DUF1086	CHD3 CHD4	1.24e-04	3	121	2	PF06461
Domain	DUF1087	CHD3 CHD4	1.24e-04	3	121	2	SM01147
Domain	DUF1086	CHD3 CHD4	1.24e-04	3	121	2	SM01146
Domain	HSA	SMARCA2 SMARCA4	2.48e-04	4	121	2	SM00573
Domain	HSA	SMARCA2 SMARCA4	2.48e-04	4	121	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	2.48e-04	4	121	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	2.48e-04	4	121	2	PF07529
Domain	Chromo_domain	CHD2 CHD3 CHD4	4.86e-04	24	121	3	IPR023780
Domain	SCAN_BOX	ZSCAN31 ZFP69 ZSCAN32 ZKSCAN3	5.43e-04	58	121	4	PS50804
Domain	BRK	SMARCA2 SMARCA4	6.14e-04	6	121	2	SM00592
Domain	BRK_domain	SMARCA2 SMARCA4	6.14e-04	6	121	2	IPR006576
Domain	BRK	SMARCA2 SMARCA4	6.14e-04	6	121	2	PF07533
Domain	Chromo	CHD2 CHD3 CHD4	6.18e-04	26	121	3	PF00385
Domain	Helicase_C	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	6.59e-04	107	121	5	PF00271
Domain	HELICc	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	6.59e-04	107	121	5	SM00490
Domain	Helicase_C	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	6.88e-04	108	121	5	IPR001650
Domain	HELICASE_CTER	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	7.17e-04	109	121	5	PS51194
Domain	HELICASE_ATP_BIND_1	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	7.17e-04	109	121	5	PS51192
Domain	DEXDc	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	7.17e-04	109	121	5	SM00487
Domain	Helicase_ATP-bd	CHD2 CHD3 CHD4 SMARCA2 SMARCA4	7.48e-04	110	121	5	IPR014001
Domain	CHROMO_1	CHD2 CHD3 CHD4	7.72e-04	28	121	3	PS00598
Domain	CHROMO_2	CHD2 CHD3 CHD4	7.72e-04	28	121	3	PS50013
Domain	Syndecan	NRXN3 NRXN2	8.56e-04	7	121	2	PF01034
Domain	Syndecan/Neurexin_dom	NRXN3 NRXN2	8.56e-04	7	121	2	IPR027789
Domain	Chromodomain-like	CHD2 CHD3 CHD4	1.15e-03	32	121	3	IPR016197
Domain	Chromo/shadow_dom	CHD2 CHD3 CHD4	1.26e-03	33	121	3	IPR000953
Domain	CHROMO	CHD2 CHD3 CHD4	1.26e-03	33	121	3	SM00298
Domain	DNA/RNA_helicase_DEAH_CS	CHD2 CHD3 CHD4	1.49e-03	35	121	3	IPR002464
Domain	DEAH_ATP_HELICASE	CHD2 CHD3 CHD4	1.90e-03	38	121	3	PS00690
Domain	ConA-like_dom	NBEAL1 CLSTN2 CLSTN1 THBS1 NRXN3 NRXN2	3.05e-03	219	121	6	IPR013320
Domain	WW	PIN1 PIN1P1 UTRN	3.49e-03	47	121	3	PF00397
Domain	Neurexin-like	NRXN3 NRXN2	3.60e-03	14	121	2	IPR003585
Domain	4.1m	NRXN3 NRXN2	3.60e-03	14	121	2	SM00294
Domain	WW	PIN1 PIN1P1 UTRN	3.71e-03	48	121	3	SM00456
Domain	zf-CCCH	MKRN4P U2AF1 RBM27	3.93e-03	49	121	3	PF00642
Domain	EGF	LAMC3 THBS1 HEG1 NRXN3 HMCN1 NRXN2	4.30e-03	235	121	6	SM00181
Domain	WW_DOMAIN_1	PIN1 PIN1P1 UTRN	4.40e-03	51	121	3	PS01159
Domain	WW_DOMAIN_2	PIN1 PIN1P1 UTRN	4.40e-03	51	121	3	PS50020
Domain	WW_dom	PIN1 PIN1P1 UTRN	4.65e-03	52	121	3	IPR001202
Domain	zf-C2H2	TSHZ3 ZNF536 ZSCAN31 ZFP69 ZNF77 ZSCAN32 ZNF37A ZNF641 ZKSCAN3 ZFP2 ZNF646	5.38e-03	693	121	11	PF00096
Domain	EGF-like_dom	LAMC3 THBS1 HEG1 NRXN3 HMCN1 NRXN2	5.68e-03	249	121	6	IPR000742
Domain	SCAN	ZSCAN31 ZSCAN32 ZKSCAN3	5.73e-03	56	121	3	SM00431
Domain	Chromodomain_CS	CHD2 CHD3	5.95e-03	18	121	2	IPR023779
Domain	Znf_CCCH	MKRN4P U2AF1 RBM27	6.32e-03	58	121	3	IPR000571
Domain	Laminin_G	THBS1 NRXN3 NRXN2	6.32e-03	58	121	3	IPR001791
Domain	SCAN	ZSCAN31 ZSCAN32 ZKSCAN3	6.32e-03	58	121	3	PF02023
Domain	SCAN_dom	ZSCAN31 ZSCAN32 ZKSCAN3	6.32e-03	58	121	3	IPR003309
Domain	EGF_1	LAMC3 THBS1 HEG1 NRXN3 HMCN1 NRXN2	6.36e-03	255	121	6	PS00022
Pathway	REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION	GAD1 CASP10 CHD3 CHD4 ZFP69 TFAP2C ZNF77 NCOR1 U2AF1 ZSCAN32 THBS1 ZNF37A SUPT6H PIN1 ZNF641 ZKSCAN3 TNRC6A PLXNA4 SMARCA2 SMARCA4 HDAC10 ZFP2	2.53e-05	1387	87	22	M734
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 TSHZ3 ZNF536 DNAJC13 CHD3 CHD4 BCR NCOR1 FASN ZKSCAN3 TNRC6A GEMIN4 UTRN	4.54e-09	418	126	13	34709266
Pubmed	Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes.	CHD3 CHD4 SMARCA2 SMARCA4	5.31e-08	11	126	4	10204490
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 SETX PAK4 BCR FRMD4B TIAM2 NRXN3 NRXN2 RBM27 SUPT6H TNRC6A KCNT1 ZNF646	7.20e-08	529	126	13	14621295
Pubmed	The contribution of rare and common variants in 30 genes to risk nicotine dependence.	ANKK1 DBH NRXN3 NRXN2	1.60e-07	14	126	4	25450229
Pubmed	Characterization of the CHD family of proteins.	CHD2 CHD3 CHD4	1.85e-07	4	126	3	9326634
Pubmed	Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins.	GAD1 CLSTN2 CLSTN1 NRXN3 NRXN2	1.31e-06	52	126	5	24613359
Pubmed	Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit.	NRXN3 PTPRD NRXN2	2.57e-06	8	126	3	37591863
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	USP34 PNKP INCENP CHD2 CHD3 CHD4 MED13L TFAP2C NCOR1 FASN RBM27 SUPT6H PIN1 SMARCA2 SMARCA4	4.26e-06	1014	126	15	32416067
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 INCENP CHD2 CHD4 FASN SUPT6H SMARCA2 GEMIN4 SMARCA4 SNX9 UTRN HERC5	4.82e-06	653	126	12	22586326
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	PNKP CHD3 CHD4 NCOR1 SUPT6H SMARCA2 SMARCA4	4.96e-06	183	126	7	36129980
Pubmed	A genome-wide association study provides evidence for association of chromosome 8p23 (MYP10) and 10q21.1 (MYP15) with high myopia in the French Population.	ZNF536 CHD4 CLSTN2 PTPRD	5.46e-06	32	126	4	23049088
Pubmed	ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF.	THBS1 SMARCA2 SMARCA4	5.47e-06	10	126	3	23129809
Pubmed	The C. elegans homolog of human panic-disorder risk gene TMEM132D orchestrates neuronal morphogenesis through the WAVE-regulatory complex.	ANKRD31 COX11 PNISR PTPRD LNX1	6.64e-06	72	126	5	33726789
Pubmed	Portal osmopressor mechanism linked to transient receptor potential vanilloid 4 and blood pressure control.	DBH TRPV4	1.30e-05	2	126	2	20385965
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	1.30e-05	2	126	2	8670841
Pubmed	Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen.	CHD3 CHD4	1.30e-05	2	126	2	7560064
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	1.30e-05	2	126	2	23163725
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	1.30e-05	2	126	2	23076393
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	1.30e-05	2	126	2	15576411
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	1.30e-05	2	126	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	1.30e-05	2	126	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	1.30e-05	2	126	2	33027072
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	1.30e-05	2	126	2	23872584
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	1.30e-05	2	126	2	23088494
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	1.30e-05	2	126	2	20333683
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	1.30e-05	2	126	2	34812766
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	1.30e-05	2	126	2	30478150
Pubmed	The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation.	CHD3 CHD4	1.30e-05	2	126	2	7575689
Pubmed	TRIM8 is required for virus-induced IFN response in human plasmacytoid dendritic cells.	PIN1 TRIM8	1.30e-05	2	126	2	31799391
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	1.30e-05	2	126	2	25808524
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	1.30e-05	2	126	2	19144648
Pubmed	A20 inhibits toll-like receptor 2- and 4-mediated interleukin-8 synthesis in airway epithelial cells.	TICAM1 TNFAIP3	1.30e-05	2	126	2	15142865
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	1.30e-05	2	126	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	1.30e-05	2	126	2	37634210
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	1.30e-05	2	126	2	8208605
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	1.30e-05	2	126	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	1.30e-05	2	126	2	12620226
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	1.30e-05	2	126	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	1.30e-05	2	126	2	29848589
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	1.30e-05	2	126	2	9603422
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	1.30e-05	2	126	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	1.30e-05	2	126	2	27097303
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	1.30e-05	2	126	2	28038711
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	1.30e-05	2	126	2	23963727
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	1.30e-05	2	126	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	1.30e-05	2	126	2	31375262
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	1.30e-05	2	126	2	17075831
Pubmed	The human PIN1 peptidyl-prolyl cis/trans isomerase gene maps to human chromosome 19p13 and the closely related PIN1L gene to 1p31.	PIN1 PIN1P1	1.30e-05	2	126	2	9299231
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	1.30e-05	2	126	2	32855269
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	1.30e-05	2	126	2	22721696
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	1.30e-05	2	126	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	1.30e-05	2	126	2	11719516
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	1.30e-05	2	126	2	28706277
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	1.30e-05	2	126	2	21092585
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	1.30e-05	2	126	2	26551623
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	1.30e-05	2	126	2	19458193
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	1.30e-05	2	126	2	34289068
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	1.30e-05	2	126	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	1.30e-05	2	126	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	1.30e-05	2	126	2	26356327
Pubmed	Mouse Chd4-NURD is required for neonatal spermatogonia survival and normal gonad development.	CHD3 CHD4	1.30e-05	2	126	2	35568926
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	1.30e-05	2	126	2	12566296
Pubmed	Two forms of the major antigenic protein of the dermatomyositis-specific Mi-2 autoantigen.	CHD3 CHD4	1.30e-05	2	126	2	8843877
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	1.30e-05	2	126	2	31406271
Pubmed	Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.	SMARCA2 SMARCA4	1.30e-05	2	126	2	29273066
Pubmed	Human Melanoma cells over-express extracellular matrix 1 (ECM1) which is regulated by TFAP2C.	ECM1 TFAP2C	1.30e-05	2	126	2	24023917
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	ZNF536 CHD3 NCOR1 SMARCA2 SMARCA4	1.33e-05	83	126	5	28794006
Pubmed	Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1.	CHD4 PIN1 SMARCA2 SMARCA4	1.36e-05	40	126	4	34585037
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	CHD2 CHD3 CHD4 SMARCA2 SMARCA4 HDAC10	2.42e-05	157	126	6	30186101
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOR1 SMARCA2 SMARCA4	3.04e-05	17	126	3	19183483
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	CHD4 SMARCA2 SMARCA4	3.64e-05	18	126	3	28068325
Pubmed	Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.	SPHK2 MANBA REV3L MST1 FCGR2A MICB LSP1 TNFAIP3	3.70e-05	342	126	8	23128233
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	TSHZ3 CHD3 CHD4 SMARCA2 SMARCA4	3.80e-05	103	126	5	32744500
Pubmed	Conditional Knockout of Neurexins Alters the Contribution of Calcium Channel Subtypes to Presynaptic Ca2+ Influx.	NRXN3 NRXN2	3.90e-05	3	126	2	38891114
Pubmed	DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1.	SMARCA2 SMARCA4	3.90e-05	3	126	2	30287812
Pubmed	Identification of a novel ANKK1 and other dopaminergic (DRD2 and DBH) gene variants in migraine susceptibility.	ANKK1 DBH	3.90e-05	3	126	2	22875483
Pubmed	The calsyntenins--a family of postsynaptic membrane proteins with distinct neuronal expression patterns.	CLSTN2 CLSTN1	3.90e-05	3	126	2	12498782
Pubmed	Polymorphisms in the DBH and DRD2 gene regions and smoking behavior.	ANKK1 DBH	3.90e-05	3	126	2	16032443
Pubmed	The mouse Jhy gene regulates ependymal cell differentiation and ciliogenesis.	CDH2 JHY	3.90e-05	3	126	2	29211732
Pubmed	alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.	NRXN3 NRXN2	3.90e-05	3	126	2	16406382
Pubmed	Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells.	USP34 PIN1	3.90e-05	3	126	2	38167292
Pubmed	BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.	SMARCA2 SMARCA4	3.90e-05	3	126	2	15034933
Pubmed	Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.	NRXN3 NRXN2	3.90e-05	3	126	2	31005376
Pubmed	Regulation of CHD2 expression by the Chaserr long noncoding RNA gene is essential for viability.	CHD2 CDH2	3.90e-05	3	126	2	31704914
Pubmed	The chromatin-remodeling enzymes BRG1 and CHD4 antagonistically regulate vascular Wnt signaling.	CHD4 SMARCA4	3.90e-05	3	126	2	22290435
Pubmed	The chromatin-remodeling enzyme CHD3 plays a role in embryonic viability but is dispensable for early vascular development.	CHD3 CHD4	3.90e-05	3	126	2	32658897
Pubmed	A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2 alpha and BRG-1/hSNF2 beta and localizes in the Golgi apparatus.	SMARCA2 SMARCA4	3.90e-05	3	126	2	12044884
Pubmed	SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.	SMARCA2 SMARCA4	3.90e-05	3	126	2	21518954
Pubmed	Characterization of mammary tumors from Brg1 heterozygous mice.	SMARCA2 SMARCA4	3.90e-05	3	126	2	17637742
Pubmed	Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals.	NRXN3 NRXN2	3.90e-05	3	126	2	26446217
Pubmed	Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.	NRXN3 NRXN2	3.90e-05	3	126	2	11944992
Pubmed	Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosis.	NRXN3 NRXN2	3.90e-05	3	126	2	33058888
Pubmed	Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.	NRXN3 NRXN2	3.90e-05	3	126	2	17035546
Pubmed	Neurexins: three genes and 1001 products.	NRXN3 NRXN2	3.90e-05	3	126	2	9448462
Pubmed	Deletion of α-neurexin II results in autism-related behaviors in mice.	NRXN3 NRXN2	3.90e-05	3	126	2	25423136
Pubmed	Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.	NRXN3 NRXN2	3.90e-05	3	126	2	34133920
Pubmed	Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.	SMARCA2 SMARCA4	3.90e-05	3	126	2	28292935
Pubmed	Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.	SMARCA2 SMARCA4	3.90e-05	3	126	2	36464671
Pubmed	The within-subject application of diffusion tensor MRI and CLARITY reveals brain structural changes in Nrxn2 deletion mice.	NRXN3 NRXN2	3.90e-05	3	126	2	30858964
Pubmed	Neurexins 1-3 Each Have a Distinct Pattern of Expression in the Early Developing Human Cerebral Cortex.	NRXN3 NRXN2	3.90e-05	3	126	2	28013231
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	TSHZ3 ZNF536 ZSCAN31 ZFP69 ZNF77 ZSCAN32 ZNF37A ZNF641 ZKSCAN3 ZFP2 ZNF646	3.85e-04	718	82	11	28
GeneFamily	PHD finger proteins\|NuRD complex	CHD3 CHD4	1.30e-03	12	82	2	1305
Coexpression	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	SETX CHD4 IFIT1 RFWD3 HEG1 SMARCA4 HERC5	1.79e-05	170	125	7	M5657
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	TSHZ3 SETX CACUL1 COX11 CHD2 MED13L ITPKB ZNF77 PTPRD SMARCA2 MIOS SMARCA4 TNFAIP3 BCAR3 QKI SNX9	2.52e-05	1009	125	16	M157
Coexpression	ROETH_TERT_TARGETS_UP	IFIT1 HEG1 HERC5	3.71e-05	14	125	3	M18660
Coexpression	GSE14000_UNSTIM_VS_4H_LPS_DC_UP	SPHK2 TMEM94 BCR ZNF77 MYG1 ZNF641 SMARCA4	4.60e-05	197	125	7	M3345
Coexpression	GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	MANBA MFHAS1 CHD2 CHD3 TRIM8 HDAC10 SNX9	4.75e-05	198	125	7	M9119
Coexpression	GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP	USP34 CLSTN1 PNISR ITPKB FASN HEG1 TNFAIP3	4.90e-05	199	125	7	M8324
Coexpression	GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN	CLSTN1 BCR IFIT1 MISP PNMA8A SMARCA2 HERC5	4.90e-05	199	125	7	M9599
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN	TSHZ3 CACUL1 COX11 ITPKB ZNF77 SMARCA2 MIOS TNFAIP3 QKI SNX9	4.92e-05	438	125	10	M227
Coexpression	GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN	USP34 CHD3 PNISR ITPKB FASN HEG1 TNFAIP3	5.06e-05	200	125	7	M8306
Coexpression	GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN	USP34 CHD3 CLSTN1 PNISR ITPKB FASN HEG1	5.06e-05	200	125	7	M8331
Coexpression	GSE27786_LSK_VS_CD4_TCELL_DN	SPHK2 SETX MFHAS1 DBH TNRC6A LSP1 JHY	5.06e-05	200	125	7	M4747
Coexpression	KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3	GAD1 POLG CHD3 CLSTN1 BCR TFAP2C MISP THBS1 MELTF MSANTD3 TRIM8 MIOS BCAR3 QKI	5.13e-05	843	125	14	M2356
Coexpression	HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN	MFHAS1 TMEM94 IFIT1 THBS1	7.50e-05	47	125	4	M40911
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	CHD4 RFWD3 NCOR1 PTPRD RBM27 TNRC6A TRIM8 SMARCA2 GOLIM4 LSP1	8.37e-05	467	125	10	M1347
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	USP34 CHD3 MED13L SMARCA4 TNFAIP3	1.03e-04	97	125	5	M14698
Coexpression	SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	CHD4 RFWD3 NCOR1 PTPRD RBM27 TNRC6A TRIM8 SMARCA2 GOLIM4 LSP1	1.12e-04	484	125	10	MM999
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000	DNAJC13 NBEAL1 CHD2 PNISR FRMD4B HEG1 TNRC6A UTRN	2.61e-05	210	120	8	gudmap_developingGonad_e18.5_ovary_1000_k2
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000	DNAJC13 NBEAL1 CHD2 CLSTN2 PNISR FRMD4B HEG1 CDH2 UTRN	2.69e-05	275	120	9	gudmap_developingGonad_e14.5_ epididymis_1000_k3
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500	DNAJC13 CHD2 PNISR FRMD4B TFAP2C HEG1 UTRN	3.67e-05	161	120	7	gudmap_developingGonad_e12.5_ovary_k3_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000	GAD1 DNAJC13 NBEAL1 CHD2 ECM1 PNISR FRMD4B HEG1 NRXN3 ZKSCAN3 TNRC6A SMARCA2 RBM46 LSP1 UTRN	3.97e-05	790	120	15	gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#3_top-relative-expression-ranked_1000	DNAJC13 NBEAL1 CHD2 PNISR FRMD4B HEG1 ZKSCAN3 UTRN	4.26e-05	225	120	8	gudmap_developingGonad_e14.5_ ovary_1000_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	DNAJC13 NBEAL1 CHD2 CLSTN2 ECM1 PNISR FRMD4B HEG1 ZKSCAN3 TNRC6A SMARCA2 SMARCA4 RBM46 CDH2 UTRN	4.65e-05	801	120	15	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000	DNAJC13 NBEAL1 CHD2 CLSTN2 PNISR FRMD4B HEG1 CDH2 UTRN	9.30e-05	323	120	9	gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500	DNAJC13 CHD2 PNISR FRMD4B TFAP2C ZKSCAN3 SMARCA4 RBM46 QKI UTRN	9.85e-05	403	120	10	gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	GAD1 DNAJC13 CHD2 PNISR FRMD4B HEG1 ZKSCAN3 RBM46 LSP1 UTRN	1.05e-04	406	120	10	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_500	DNAJC13 CHD2 PNISR FRMD4B TFAP2C HEG1 ZKSCAN3 RBM46 QKI UTRN	1.11e-04	409	120	10	gudmap_developingGonad_e12.5_ovary_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	DNAJC13 CHD2 ECM1 PNISR FRMD4B HEG1 ZKSCAN3 RBM46 CDH2 UTRN	1.20e-04	413	120	10	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000	USP34 DNAJC13 NBEAL1 CHD2 CLSTN2 PNISR FRMD4B THBS1 HEG1 HMCN1 ZKSCAN3 TNRC6A RBM46 UTRN	1.29e-04	778	120	14	gudmap_developingGonad_e18.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4	ZNF536 FRMD4B NRXN2 QKI CDH2 ZFP2	1.29e-04	137	120	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4
CoexpressionAtlas	DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000	DNAJC13 NBEAL1 CHD2 PNISR FRMD4B TFAP2C HEG1 ZKSCAN3 SMARCA4 RBM46 QKI DHTKD1 CDH2 UTRN	1.81e-04	804	120	14	gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#4	ZNF536 NRXN2 QKI CDH2 ZFP2	2.26e-04	97	120	5	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K4
CoexpressionAtlas	dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_1000	CHD3 REV3L MED13L FRMD4B HMCN1	2.26e-04	97	120	5	gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k2_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	ZNF536 FRMD4B NRXN3 NRXN2 QKI CDH2 ZFP2	2.95e-04	225	120	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4
ToppCell	Control-Control-Lymphocyte-T/NK-NK_activated\|Control / Disease, condition lineage and cell class	SETX INCENP IFIT1 ITPKB HEG1 NRXN2 SUPT6H SMARCA2 GOLIM4 UTRN ZFP2	1.09e-11	198	125	11	76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SETX CHD2 MED13L PNISR IFIT1 TNFAIP3 QKI UTRN HERC5	2.74e-10	200	125	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 SETX CASP10 IFIT1 FAM171A1 HEG1 HMCN1 UTRN	9.99e-08	200	125	8	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	PPP1R12B CHD2 BCR FAM171A1 ZNF37A TRIM8 DHTKD1	6.99e-07	177	125	7	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4\|TCGA-Pancreas / Sample_Type by Project: Shred V9	RGS22 CLSTN2 REV3L MED13L HMCN1 QKI UTRN	9.06e-07	184	125	7	67164bb6bcae7322cb89b585c7aa10bce35b0ecd
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHD4 HEG1 HMCN1 SMARCA2 SMARCA4 UTRN SCN3B	1.12e-06	190	125	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 QKI UTRN	1.29e-06	194	125	7	6ac759828c41ffa974ee82842162caa959351dd1
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 QKI UTRN	1.29e-06	194	125	7	5d0b0d8e96f0e0297a4dba70a05d87081a4eb323
ToppCell	Fibroblast-B_(Myofibroblast)\|World / shred on cell class and cell subclass (v4)	ZNF536 THBS1 NRXN3 HMCN1 PLXNA4 GOLIM4 LSP1	1.34e-06	195	125	7	a8d6416518f226e1ec2d6bdc9d4b90cef5cb1365
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	USP34 CHD2 PNISR SMARCA2 TNFAIP3 UTRN	6.54e-06	162	125	6	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-6\|TCGA-Liver / Sample_Type by Project: Shred V9	TSHZ3 PPP1R12B RGS22 SIRPB2 CLSTN2 ITPKB	8.33e-06	169	125	6	e992530776cab922d0360b275fb9cb8bd0017b06
ToppCell	facs-Skin-nan-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ECM1 MISP MELTF TRPV4 DHTKD1 JHY	1.02e-05	175	125	6	f1166b567bca80dac3abe90c3dc544c831006640
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B GOLIM4	1.16e-05	179	125	6	d1365d48d1b017a7917f4f63a82ac4720c3d87df
ToppCell	3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 CCDC9B NRXN3 HMCN1 QKI CDH2	1.23e-05	181	125	6	a436e7e4c36403257ea90160a58ca0d6d7c0cdfc
ToppCell	facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ENAM HEG1 PLXNA4 SMARCA2 GOLIM4 UTRN	1.23e-05	181	125	6	4ea02344e1996f264dd5e14f3b19c8782ce41699
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	ANKK1 LCT IFIT1 FRMD4B UTRN	1.29e-05	107	125	5	fc07dd90f280191bd643398eac5c8273651d0925
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	CHD2 IFIT1 THBS1 TNFAIP3 UTRN HERC5	1.31e-05	183	125	6	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX CHD4 NCOR1 THBS1 SNX9 UTRN	1.35e-05	184	125	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B GOLIM4	1.39e-05	185	125	6	f4ac62009c0ad3346e71b809e17727303c4df153
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 CHD2 MED13L U2AF1 TNFAIP3 UTRN	1.53e-05	188	125	6	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	GAD1 MFHAS1 ITPKB FAM171A1 HMCN1 LNX1	1.57e-05	189	125	6	f51cdc9a47371cab8ed9ae63a6f14da07ede446c
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B GOLIM4	1.62e-05	190	125	6	0acf1d5da68db449d8c9e70519a236ce825f9d11
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	BCR PKHD1L1 FRMD4B HEG1 NRXN3 HMCN1	1.77e-05	193	125	6	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	USP34 MANBA MED13L QKI SNX9 UTRN	1.77e-05	193	125	6	779276e775cb2492e8dd36436295a536084a6415
ToppCell	Control-Endothelial-Endothelial-Gen_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CASP10 ITPKB FAM171A1 PTPRD HMCN1 SMARCA2	1.77e-05	193	125	6	e1d546165dcc2392f540162206852c4717d7306f
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 UTRN	1.82e-05	194	125	6	52aebb0b563e2c2058e7f0554ae870e47692b163
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2\|World / Primary Cells by Cluster	GAD1 ZNF536 REV3L NRXN3 NRXN2 SCN3B	1.82e-05	194	125	6	b42fd64b0fb95434a9e4e6586f31d26114a4074b
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10\|World / Primary Cells by Cluster	GAD1 ZNF536 REV3L NRXN3 NRXN2 SCN3B	1.82e-05	194	125	6	81e7bc6516ab8d02ccd1c76a56a3533b788c27c8
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCBLD1 CLSTN1 HEG1 HMCN1 QKI SCN3B	1.82e-05	194	125	6	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 UTRN	1.82e-05	194	125	6	bd06e2b8d8c06cddf2e4f58849b86e09013acae1
ToppCell	MatrixFB-Fibroblast-B_(Myofibroblast)\|MatrixFB / shred on cell class and cell subclass (v4)	ZNF536 THBS1 NRXN3 HMCN1 PLXNA4 LSP1	1.93e-05	196	125	6	38ea0eaf42f95c321ca23570d0d7752980cf00f8
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 THBS1 HMCN1 PLXNA4 GOLIM4 LSP1	1.99e-05	197	125	6	26475b9e4d6bfc0ae818dea13d139888ed7e92f1
ToppCell	P03-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ZNF536 THBS1 NRXN3 HMCN1 PLXNA4 LSP1	1.99e-05	197	125	6	2cec938caf6ffd031cea37277071487e59b2c71c
ToppCell	P03-Mesenchymal-myocytic_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ZNF536 THBS1 NRXN3 HMCN1 PLXNA4 LSP1	1.99e-05	197	125	6	079db904a08743b3c555cb7b3f5fb5c978dde25a
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 THBS1 NRXN3 HMCN1 GOLIM4 LSP1	1.99e-05	197	125	6	9d7a1c7dc70ba5e35645f19f9e056e4fa2494aa0
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 THBS1 NRXN3 HMCN1 GOLIM4 LSP1	1.99e-05	197	125	6	090a251194da3e2806989d9a522588f83f52da7f
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 THBS1 NRXN3 HMCN1 GOLIM4 LSP1	1.99e-05	197	125	6	43b5f8e917506c1717f9311584901b506ffd2c79
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 THBS1 HMCN1 PLXNA4 GOLIM4 LSP1	1.99e-05	197	125	6	155e63b33302a87393ace699b2f6d73abe9c5763
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	GAD1 TIAM2 NRXN3 NRXN2 CORO7 SCN3B	2.04e-05	198	125	6	b73b9feb82997b654718aa27f33ca7b454214802
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF536 THBS1 HMCN1 PLXNA4 GOLIM4 LSP1	2.04e-05	198	125	6	a4005a49cf6709b543994ceb51ecd5dc46197fa9
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	GAD1 ZNF536 PNISR TIAM2 NRXN3 PTPRD	2.04e-05	198	125	6	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	(02)_MMP9/10+-(1)_GFP\|(02)_MMP9/10+ / shred by cell type by condition	MISP THBS1 TRPV4 TNFAIP3 BCAR3 CDH2	2.10e-05	199	125	6	448ba982be804007f991d469eca9d885b21ae499
ToppCell	(03)_KRT6B+-(2)_GFP_FOXI1\|(03)_KRT6B+ / shred by cell type by condition	PPP1R12B REV3L NCOR1 TRIM8 SMARCA2 UTRN	2.10e-05	199	125	6	c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B GOLIM4	2.16e-05	200	125	6	3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 NRXN3 SMARCA2 QKI HERC5	2.16e-05	200	125	6	f3c710f0fc8a7bfb5371d1aff6e3d8f266953153
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2--L1-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 QKI	2.16e-05	200	125	6	f268cb1bb047e88913a828614b0a77871f5f8814
ToppCell	Neuronal-Inhibitory\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 FRMD4B HEG1 QKI	2.16e-05	200	125	6	9ff8647e2de0b538e15929dca88ebb20ff7ab043
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 QKI	2.16e-05	200	125	6	5ff9ac97ef970b3b74ebb07f62a0a1f4176a10b4
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B GOLIM4	2.16e-05	200	125	6	97a010a1b6d551239cf6ea5a43319fb413ff180e
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 NRXN3 SMARCA2 QKI HERC5	2.16e-05	200	125	6	70a06fd7fb8de2c8ec3e3182e4476ced049daeae
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 QKI UTRN	2.16e-05	200	125	6	862db57d043bdf3cb059fbfc8b29bc1eafdf64ec
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	CHD4 NRXN3 NRXN2 PLXNA4 TRIM8 SCN3B	2.16e-05	200	125	6	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 QKI	2.16e-05	200	125	6	e90155498397524b812c46f2412320230b445bb6
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 QKI UTRN	2.16e-05	200	125	6	a91345f268f13170c27309333603eb82400c9947
ToppCell	Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B GOLIM4	2.16e-05	200	125	6	8ccf2dbbe34b26fbf2bbef1e64b4ae636edd6672
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SETX CASP10 IFIT1 FAM171A1 HEG1 UTRN	2.16e-05	200	125	6	a2b9d1cd291d17abddc3ee2e242121412c864b8b
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 NRXN3 SMARCA2 QKI HERC5	2.16e-05	200	125	6	1639982d9d994918f7912d12d9d7cfcbc9da4145
ToppCell	Neuronal-Inhibitory-iA-iA_2(LAMP5)-LCP2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 GOLIM4 QKI	2.16e-05	200	125	6	7345cc7dc24b9174541a3e68ecac8c4c092be400
ToppCell	Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	GAD1 ZNF536 FRMPD1 HEG1 QKI UTRN	2.16e-05	200	125	6	d416a7be1a4e6232fb58a9687774da24821f1fdd
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / Treatment groups by lineage, cell group, cell type	BCR FRMD4B HEG1 HMCN1 SMARCA2 GOLIM4	2.16e-05	200	125	6	b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Artery\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	BCR FRMD4B TIAM2 HEG1 HMCN1 GOLIM4	2.16e-05	200	125	6	b1ff8d61b567f85006d6d20093f9c803b6d34674
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons\|GW23 / Sample Type, Dataset, Time_group, and Cell type.	GAD1 TSHZ3 ZNF536 NRXN3 NRXN2 CDH2	2.16e-05	200	125	6	c6bbd33bca86ac7a76a7ba704b3e141237d04549
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	LCT IFIT1 FRMD4B GOLIM4 UTRN	2.44e-05	122	125	5	eae9d94f8510ac0f434942451d55c7260977b178
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B\|E18.5-samps / Age Group, Lineage, Cell class and subclass	GAD1 ATG9B ECM1 NRXN3 PLXNA4	4.26e-05	137	125	5	b553958e7e6dcd887d860e34d3983cbb85cefaa6
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CCDC9B RGS22 ECM1 ITPKB QSOX1	5.05e-05	142	125	5	d2d150e3019a5b7b143e50b1c1c2b6764abf36bf
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-OPC_related-Oligodendrocyte/OPC\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	CCDC9B RGS22 ECM1 ITPKB QSOX1	5.05e-05	142	125	5	43e72e4b9ae33768672ef90c8bbfd2ca1818c746
ToppCell	NS-critical-d_16-33-Myeloid-Monocyte-derived_Macrophage\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAJC13 POLG IFIT1 FCGR2A HERC5	7.19e-05	153	125	5	859de35b24c5d7d73be1c213b90b43362ee2e0eb
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD1 ATG9B IFIT1 FRMD4B UTRN	9.15e-05	161	125	5	dccb61d5e17a8f1c6d1fc146ee389f567659a0f0
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DBH TEKT5 TFAP2C MISP ASB11	9.42e-05	162	125	5	3dc39db0d5f6f3d7bcc312a6bce7aaeb914138d1
ToppCell	facs-Thymus-Epithelium-3m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DBH TEKT5 TFAP2C MISP ASB11	9.42e-05	162	125	5	0a7138266054ea5954649c8b61ef93905d56b068
ToppCell	facs-Thymus-Epithelium-3m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DBH TEKT5 TFAP2C MISP ASB11	9.42e-05	162	125	5	25323785dd33337bcefd05958a4a1a208a9ceb04
ToppCell	control-Epithelial-Ionocyte\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ZSCAN31 PPP1R12B ENAM THBS1 CDH2	1.03e-04	165	125	5	5cfba9a46bd8ceeca74a6493057b4d38af6b06fe
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLSTN2 LCT RPTN PLXNA4 SCN3B	1.09e-04	167	125	5	3dfec2fcc36caa6e394efae5e540a6fa28759977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLSTN2 LCT RPTN PLXNA4 SCN3B	1.09e-04	167	125	5	95b3b5ba3414729f0460a26a0deca48de0cbe33e
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLSTN2 LCT RPTN PLXNA4 SCN3B	1.09e-04	167	125	5	9480739587d51e67a281778b9bddd7b5ffc3ad92
ToppCell	control-Epithelial-Ionocyte\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ZSCAN31 PPP1R12B ENAM THBS1 CDH2	1.12e-04	168	125	5	327b02f19f4a8607c033203824fdc60a1254331f
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 NRXN3 TRPV4 BCAR3 CDH2	1.12e-04	168	125	5	95dc690c1987b05685d36e6bb20eb79308696e30
ToppCell	343B-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	FRMPD1 ENAM ZKSCAN3 PLXNA4 DHTKD1	1.15e-04	169	125	5	632aa3ab39ec87bafcefec6cddf71129a054d3b0
ToppCell	Frontal_cortex-Neuronal-Inhibitory\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	GAD1 ZNF536 ATG9B NRXN3 TNRC6A	1.15e-04	169	125	5	78eb70dd916724e476eabccf18fb7fcec4210308
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ATG9B FAM171A1 HEG1 NRXN3 TRPV4	1.15e-04	169	125	5	f086b50791e1c93e253eb5e8d6c4bf617b1416c3
ToppCell	356C-Myeloid-Dendritic-cDC_activated\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	CDC20B CHD3 TIAM2 NRXN2 FOXD4	1.18e-04	170	125	5	513d9036aa41d4d902da8baa66a66206abb6f3b0
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	GAD1 ATG9B IFIT1 FRMD4B UTRN	1.18e-04	170	125	5	8ab67e2b6e30fdf9e9a2c02e31d4df34e751a3ed
ToppCell	facs\|World / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CLSTN1 ECM1 QSOX1 HEG1 SNX9	1.21e-04	171	125	5	bb71e816dde44fda6af0ad98d979be9f8740fda6
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ANKRD31 FRMPD1 DCBLD1 LAMC3 SCN3B	1.21e-04	171	125	5	b73a365ab3743d1fb7195abfbd76ef779f542cc2
ToppCell	facs\|World / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLSTN1 ECM1 QSOX1 HEG1 SNX9	1.21e-04	171	125	5	5bcb96ed7fc15548f2dc9cf47482f890640cb39c
ToppCell	facs-Heart-LV-3m-Endothelial-endothelial_cell_of_endocardium\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCBLD1 PKHD1L1 HEG1 NRXN3 HMCN1	1.25e-04	172	125	5	f2c17c49b375b28ad47dc6cabda62f1c238023dd
ToppCell	facs-Heart-LV-3m-Endothelial-endocardial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DCBLD1 PKHD1L1 HEG1 NRXN3 HMCN1	1.25e-04	172	125	5	6ab4f01098dddb789df298ddf97b3c384405ee6c
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GAD1 ZNF536 FRMPD1 ECM1 FRMD4B	1.39e-04	176	125	5	682a1dfcc507ec540f5fadf08e872533ea9f0291
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANKK1 BCR PKHD1L1 NRXN2 UTRN	1.39e-04	176	125	5	460cb302c5b3d609c65b924e1d4e8ea057a68485
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ECM1 THBS1 MELTF NRXN2 PLXNA4	1.43e-04	177	125	5	84591e28482ab62a5ef41e61043eb64912766356
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 ZNF536 LAMC3 REV3L LSP1	1.43e-04	177	125	5	9ec7f1e64312d26d434b3312b58386715dbad644
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ECM1 THBS1 MELTF NRXN2 PLXNA4	1.43e-04	177	125	5	4bc100062891d07cacd10ffba38966cc6302c92f
ToppCell	3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Differentiating_glia\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF536 NRXN3 TRPV4 BCAR3 CDH2	1.43e-04	177	125	5	0417460bdb012bc43d7254377fa53d79cdab3f34
ToppCell	E16.5-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ECM1 THBS1 MELTF NRXN2 PLXNA4	1.43e-04	177	125	5	9f3a2adb9cd4f0a059afc87b6e377a9702154bb1
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TSHZ3 ZNF536 LAMC3 REV3L LSP1	1.43e-04	177	125	5	016277dfd59b1793fddaaadc2b3f41622d76ce3a
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAD1 IFIT1 THBS1 PLXNA4 JHY	1.46e-04	178	125	5	9e1f2596fcea5b79cc50b58d83706bb8605e224f
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAD1 IFIT1 THBS1 PLXNA4 JHY	1.46e-04	178	125	5	aa659bd283c4dfbe292cd8698bbf6b1999ca3314
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-4\|TCGA-Breast / Sample_Type by Project: Shred V9	MFHAS1 TIAM2 FAM171A1 MELTF MSANTD3	1.46e-04	178	125	5	44b5ba4e8788d3973749a1717e427647ac4c8579
ToppCell	PND10-Immune-Immune_Myeloid-Megakaryocyte/Platelet\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GAD1 IFIT1 THBS1 PLXNA4 JHY	1.46e-04	178	125	5	bf1d273802a4f42e52ea1bd2a0cae2039559c093
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FRMPD1 ITPKB FAM171A1 HMCN1 BCAR3	1.50e-04	179	125	5	666072c0e8448dbaec1683d18368ec2502453f90
Drug	Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A	USP34 GAD1 ZSCAN31 IFIT1 ITPKB SUPT6H TNFAIP3 HERC5	1.28e-05	194	126	8	2621_UP
Drug	Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; PC3; HT_HG-U133A	SETX TFAP2C THBS1 NRXN3 SMARCA2 QKI UTRN HERC5	1.43e-05	197	126	8	6758_DN
Drug	Hydroxytacrine maleate (R,S) [118909-22-1]; Up 200; 12.2uM; PC3; HT_HG-U133A	FRMPD1 CASP10 MELTF HEG1 PTPRD PNMA8A MIOS TNFAIP3	1.48e-05	198	126	8	6651_UP
Drug	Pyridoxine hydrochloride [58-56-0]; Down 200; 19.4uM; PC3; HT_HG-U133A	USP34 ZSCAN31 BCR ITPKB NCOR1 HEG1 CDH2 JHY	1.48e-05	198	126	8	5813_DN
Drug	Pentoxifylline [6493-05-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	GAD1 CHD3 PNISR BCR HEG1 SMARCA2 TNFAIP3 QKI	1.60e-05	200	126	8	2127_UP
Disease	Autism Spectrum Disorders	TSHZ3 LAMC3 CHD2 NRXN3 NRXN2	2.80e-05	85	122	5	C1510586
Disease	autism spectrum disorder (implicated_via_orthology)	TSHZ3 LAMC3 CHD2 SCAMP3 NRXN3 NRXN2	4.18e-05	152	122	6	DOID:0060041 (implicated_via_orthology)
Disease	electrodermal activity measurement	NRXN3 TNRC6A	5.07e-05	3	122	2	EFO_0006866
Disease	Mammary Carcinoma, Human	PPP1R12B MST1 NCOR1 THBS1 FASN PTPRD PIN1 LSP1 BCAR3 CDH2	6.79e-05	525	122	10	C4704874
Disease	Mammary Neoplasms, Human	PPP1R12B MST1 NCOR1 THBS1 FASN PTPRD PIN1 LSP1 BCAR3 CDH2	6.79e-05	525	122	10	C1257931
Disease	Mammary Neoplasms	PPP1R12B MST1 NCOR1 THBS1 FASN PTPRD PIN1 LSP1 BCAR3 CDH2	7.00e-05	527	122	10	C1458155
Disease	Breast Carcinoma	PPP1R12B MST1 NCOR1 THBS1 FASN PTPRD PIN1 LSP1 BCAR3 CDH2	8.31e-05	538	122	10	C0678222
Disease	Ulcerative Colitis	ECM1 MST1 FCGR2A LSP1	1.37e-04	63	122	4	C0009324
Disease	cortical surface area measurement	USP34 ZNF536 DNAJC13 NBEAL1 MFHAS1 PPP1R12B LAMC3 MED13L CLSTN1 BCR FRMD4B NCOR1 THBS1 TNRC6A TRIM8 LNX1	1.38e-04	1345	122	16	EFO_0010736
Disease	Malignant neoplasm of breast	TICAM1 PPP1R12B FRMPD1 MST1 NCOR1 THBS1 FASN PTPRD PIN1 GOLIM4 LSP1 BCAR3 CDH2 ZNF646	1.46e-04	1074	122	14	C0006142
Disease	velopharyngeal dysfunction	MFHAS1 TEKT5 PTPRD LNX1 TTC33	1.57e-04	122	122	5	EFO_0009336
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	1.68e-04	5	122	2	C3281201
Disease	vital capacity	USP34 ZSCAN31 FRMPD1 LCT TIAM2 NCOR1 THBS1 MELTF PTPRD HMCN1 PIN1 SMARCA2 LNX1 CDH2 UTRN	1.82e-04	1236	122	15	EFO_0004312
Disease	Child Development Disorders, Specific	PNKP CHD4 KCNT1	2.33e-04	29	122	3	C0085997
Disease	Child Development Deviations	PNKP CHD4 KCNT1	2.33e-04	29	122	3	C0085996
Disease	Developmental Disabilities	PNKP CHD4 KCNT1	2.58e-04	30	122	3	C0008073
Disease	Autoimmune Lymphoproliferative Syndrome	CASP10 TNFAIP3	4.67e-04	8	122	2	C1328840
Disease	pulmonary function measurement, forced expiratory volume	ZSCAN31 MICB ZKSCAN3	4.84e-04	37	122	3	EFO_0003892, EFO_0004314
Disease	Intellectual Disability	TMEM94 CHD3 MED13L FASN NRXN2 TRIM8 QKI CDH2	5.57e-04	447	122	8	C3714756
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	5.99e-04	9	122	2	DOID:0050340 (implicated_via_orthology)
Disease	pulse pressure measurement	USP34 NBEAL1 MFHAS1 CHD2 MED13L QSOX1 MELTF FASN PTPRD SUPT6H TNRC6A TRIM8 LSP1 CORO7 LNX1	6.38e-04	1392	122	15	EFO_0005763
Disease	alpha fetoprotein measurement	USP34 SETX MANBA NCOR1	8.03e-04	100	122	4	EFO_0010583
Disease	Myoclonic Astatic Epilepsy	CHD2 TNRC6A	9.10e-04	11	122	2	C0393702
Disease	selective IgA deficiency disease	FAM171A1 FASN TTC33	9.19e-04	46	122	3	EFO_1001929
Disease	psoriasis	SPHK2 MANBA REV3L MICB TNFAIP3 TTC33	9.80e-04	273	122	6	EFO_0000676
Disease	triacylglycerol 58:12 measurement	NRXN3 LNX1	1.09e-03	12	122	2	EFO_0010439
Disease	Charcot-Marie-Tooth Disease	SETX TRPV4	1.09e-03	12	122	2	C0007959
Disease	Schizophrenia	ANKK1 GAD1 ZSCAN31 CHD4 TEKT5 THBS1 NRXN3 NRXN2 MICB SMARCA2 QKI	1.11e-03	883	122	11	C0036341
Disease	pathological myopia	ZNF536 CHD4 CLSTN2 PTPRD	1.18e-03	111	122	4	EFO_0004207
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	1.28e-03	13	122	2	C0265338
Disease	Sjogren's Syndrome	FCGR2A TNFAIP3	1.28e-03	13	122	2	C1527336
Disease	Sicca Syndrome	FCGR2A TNFAIP3	1.28e-03	13	122	2	C0086981
Disease	Drug habituation	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0013170
Disease	Drug abuse	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0013146
Disease	Prescription Drug Abuse	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C4316881
Disease	Substance-Related Disorders	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0236969
Disease	Drug Use Disorders	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0013222
Disease	Drug Dependence	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C1510472
Disease	Substance Dependence	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0038580
Disease	Substance Use Disorders	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	TIAM2 QSOX1 NRXN3 BCAR3	1.35e-03	115	122	4	C0029231
Disease	Substance abuse problem	TIAM2 QSOX1 NRXN3 BCAR3	1.39e-03	116	122	4	C0740858
Disease	unipolar depression, anxiety	ZSCAN31 PTPRD	1.49e-03	14	122	2	EFO_0003761, EFO_0005230
Disease	t-tau measurement	NRXN3 PLXNA4 GOLIM4 SNX9	1.89e-03	126	122	4	EFO_0004760
Disease	Schizoaffective disorder-bipolar type	NRXN3 SCN3B	1.96e-03	16	122	2	EFO_0009965
Disease	Early infantile epileptic encephalopathy with suppression bursts	PNKP TRIM8	1.96e-03	16	122	2	C0393706
Disease	proliferative diabetic retinopathy	NRXN3 GOLIM4 UTRN	2.08e-03	61	122	3	EFO_0009322
Disease	non-Hodgkin lymphoma (is_implicated_in)	CASP10 FCGR2A	2.21e-03	17	122	2	DOID:0060060 (is_implicated_in)
Disease	rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement	RGS22 FCGR2A TNFAIP3	2.29e-03	63	122	3	EFO_0000685, EFO_0007791, EFO_0009459
Disease	Global developmental delay	TMEM94 CHD3 TRIM8 CDH2	2.30e-03	133	122	4	C0557874
Disease	age-related hearing impairment	ZNF536 CLSTN2 MED13L ZFP69 HEG1 PLXNA4	2.33e-03	324	122	6	EFO_0005782
Disease	rheumatoid arthritis, COVID-19	ZSCAN31 MICB ZKSCAN3	2.39e-03	64	122	3	EFO_0000685, MONDO_0100096
Disease	sclerosing cholangitis	MANBA MST1 TNFAIP3	2.61e-03	66	122	3	EFO_0004268
Disease	Cocaine Dependence	ANKK1 GAD1 DBH SMARCA4	2.70e-03	139	122	4	C0600427
Disease	alkaline phosphatase measurement	USP34 DNAJC13 CACUL1 MANBA MFHAS1 CHD3 DBH ITPKB TRIM8 SNX9 UTRN	3.30e-03	1015	122	11	EFO_0004533
Disease	Lymphoma, Diffuse	FPGS CASP10	3.38e-03	21	122	2	C3714542
Disease	Low Grade Lymphoma (neoplasm)	FPGS CASP10	3.38e-03	21	122	2	C0079747
Disease	Lymphoma, Intermediate-Grade	FPGS CASP10	3.38e-03	21	122	2	C0079741
Disease	High Grade Lymphoma (neoplasm)	FPGS CASP10	3.38e-03	21	122	2	C0079740
Disease	Diffuse Mixed-Cell Lymphoma	FPGS CASP10	3.38e-03	21	122	2	C0079757
Disease	systemising measurement	TSHZ3 CLSTN1	3.38e-03	21	122	2	EFO_0010221
Disease	Lymphoma, Undifferentiated	FPGS CASP10	3.38e-03	21	122	2	C0024306
Disease	Reticulosarcoma	FPGS CASP10	3.38e-03	21	122	2	C0024302
Disease	Lymphoma, Mixed-Cell	FPGS CASP10	3.38e-03	21	122	2	C0024304
Disease	myocardial infarction	ANKRD31 NBEAL1 DCBLD1 ZNF77 SMARCA4 QKI	3.41e-03	350	122	6	EFO_0000612
Disease	Lymphoma, Non-Hodgkin, Familial	FPGS CASP10	3.71e-03	22	122	2	C4721532
Disease	Lymphoma, Small Noncleaved-Cell	FPGS CASP10	3.71e-03	22	122	2	C0079770
Disease	pulse pressure measurement, alcohol consumption measurement	LSP1 LNX1	3.71e-03	22	122	2	EFO_0005763, EFO_0007878
Disease	melanoma	INCENP DCBLD1 CASP10 MELTF FASN	3.76e-03	248	122	5	C0025202
Disease	glucagon measurement	ZNF536 FRMD4B TIAM2 MELTF	3.89e-03	154	122	4	EFO_0008463
Disease	Parkinson's disease (is_implicated_in)	DNAJC13 POLG DBH	3.89e-03	76	122	3	DOID:14330 (is_implicated_in)

Protein segments in the cluster

Peptide	Gene	Start	Entry
QRNHSLDNWPNTTRV	ERVPABLB-1	216	P60509
QQRDLFATDWSQQPG	ERVPABLB-1	246	P60509
TGSQQQAWPGRQSQE	TFAP2C	96	Q92754
TQDGIQESPWQDRHG	BCAR3	86	O75815
PRVQQWSHQQRVGDL	BCR	566	P11274
GWTPLHLAAQNNFEN	ANKK1	461	Q8NFD2
RSPESDSIQWFHNGN	FCGR2A	66	P12318
QWLDTPLHAAARQSN	ASB11	226	Q8WXH4
GDPQNATRQQQLEWD	CLSTN1	961	O94985
QDLWTVNGLPNENNS	ANGEL2	516	Q5VTE6
QAHWQGLAQPEAQIT	DHTKD1	506	Q96HY7
HGQNGARQAQLEWDD	CLSTN2	936	Q9H4D0
SSPPWDHGNQRQEAA	CCDC140	16	Q96MF4
HLAQQQEPWSRLNST	CFAP276	36	Q5T5A4
NHNNWEAAVDGFRQP	CACUL1	21	Q86Y37
GTSSRNPGQQRNHFW	MKRN4P	441	Q13434
PDAAHQISQQVGWQD	NBEAL1	1251	Q6ZS30
WHRENNEQPTLQSSA	RBM27	671	Q9P2N5
KENTWRQHLNGQISP	RBM46	311	Q8TBY0
EQNRGKPNWEHLNED	QKI	136	Q96PU8
NEQEQPLGQWHLSKR	QSOX1	631	O00391
HQSQNLQQPRGSQAW	RFWD3	406	Q6PCD5
VNLNDNAGWTPLHEA	ANKRD31	1181	Q8N7Z5
SQNQHQPPENWAEAL	PNMA8A	136	Q86V59
KAETPNNWNATEDQH	PNMA8A	211	Q86V59
DEPQTWPTDHRAQQG	MISP	46	Q8IVT2
WPTDHRAQQGVQRQG	MISP	51	Q8IVT2
QHLQDAGTREWSPQN	FAM171A1	646	Q5VUB5
QPWSGEENDNHSRLK	MED13L	1486	Q71F56
HTWDQGANNRQQPIE	JHY	106	Q6NUN7
EVPENNGNNSWPHND	INCENP	391	Q9NQS7
NGNNSWPHNDTEIAN	INCENP	396	Q9NQS7
NEVPHAEAWINGTNL	MFHAS1	856	Q9Y4C4
RLNPTWNHPDQDTEA	MYG1	201	Q9HB07
SVVIGRHQNPWQECN	LIPT1	71	Q9Y234
HTSRGQEGQESPEQW	KCNT1	516	Q5JUK3
PQTHNARDQWLQDAF	FAM89B	171	Q8N5H3
SKQQPLGWSNHQAEL	CCDC9B	456	Q6ZUT6
HQDQIFSLAWSPDGQ	CORO7	636	P57737
NGIERANSVTWNPHK	GAD1	391	Q99259
NHITNASQWERPSGN	PIN1	26	Q13526
QHCPAQESQWLELSG	PLXNA4	836	Q9HCM2
NHITNPSQWERPSGN	PIN1P1	26	O15428
PNWVSPSDHQRAQIN	FAM205BP	226	Q63HN1
NSDKPVNDNQWHNVV	NRXN2	991	Q9P2S2
IKGNSDRPLNDNQWH	NRXN3	941	Q9Y4C0
PTQRDWQEQLVVGHN	POLG	256	P54098
QRSPDIFQEAGWNSN	LNX1	466	Q8TBB1
PQALQDHGGWQNESV	LCT	501	P09848
QRTWQALAHEYNSQP	MSANTD3	46	Q96H12
LSHNTQQWGDVLPDG	MICB	246	Q29980
RWQNDSPTFGEHQLA	HEG1	411	Q9ULI3
PAWQNSIRHNLSLND	FOXD4	146	Q12950
WQKEGINVNTSGRNH	HMCN1	4021	Q96RW7
NDVWQNHEAVPGRAE	GOLIM4	286	O00461
FNVHWDRNDTNLIPN	HERC5	836	Q9UII4
DDTGQQNWLQLDHRV	FRMD4B	106	Q9Y2L6
ARAAQAPHWKSLQQQ	HDAC10	346	Q969S8
DSDWNPQNDLQAQAR	CHD2	886	O14647
SDWNPHNDIQAFSRA	CHD3	1156	Q12873
ADVHASLQWNFRPQQ	COX11	156	Q9Y6N1
LWPGNKQQAHRVSAE	FRMPD1	501	Q5SYB0
WSDQKGQIHLDPQQD	DBH	116	P09172
EPQGLDAASWAQIHQ	CCDC78	376	A2IDD5
LHQQQQQQEPWGEAA	ATG9B	841	Q674R7
GTHENPELIWNDNSR	DNAJC13	1921	O75165
HPSIIIWSGNNENEE	MANBA	446	O00462
HDNQANVRSLVTWGN	IFIT1	86	P09914
FGDWSQRPEQRQQHE	LSP1	81	P33241
WNGENHNGIENIDLS	CDC20B	256	Q86Y33
QQHWNHLDEEQASPD	FPGS	471	Q05932
ALPQESWQNKHAGSN	CASP10	226	Q92851
EPESWNAAQHCQQDR	ECM1	141	Q16610
PSRNSWDHRIQAQGQ	ENAM	761	Q9NRM1
NSPWTVSLRNRQGQH	MST1	491	P26927
DQVHWSPGQARLQDQ	DCBLD1	281	Q8N8Z6
ELQQHDVAQGQWDPA	FASN	1286	P49327
SDWNPHNDIQAFSRA	CHD4	1146	Q14839
DWHPENQNLSQVSDP	RSC1A1	151	Q92681
QHAALGGTATRQNNW	SCAMP3	121	O14828
NDNRPEFLHQVWNGT	CDH2	261	P19022
DQHEQKFTGLPRQWQ	PAK4	26	O96013
PGQQFTWEHSNLEVN	PTPRD	1366	P23468
PDQNNIWIRDHEDSG	MEIS3P1	96	A6NDR6
QWDGTQHGVELRQQQ	UTRN	2316	P46939
RNTNTPNNWDTAFGH	SNX9	136	Q9Y5X1
SDWNPHQDLQAQDRA	SMARCA2	1146	P51531
NTNGHNSEPWAAELR	MELTF	581	P08582
DGSQWNEEHLRNIQS	RGS22	481	Q8NE09
EGQTLQHDVPWQEGN	ITPKB	906	P27987
SAVNQAAPHQQNRIW	NCOR1	2406	O75376
SDWNPHQDLQAQDRA	SMARCA4	1176	P51532
QLSAAELQSRNQGHW	SELENOO	541	Q9BVL4
SVWQDHPDDNNSVQD	SETX	1091	Q7Z333
PHDWDQSNQLQVRGA	TEKT5	91	Q96M29
WDHLQEQANDGTPIS	PNKP	266	Q96T60
GFTQEEWQHLDPAQR	ZNF37A	16	P17032
QQQPKSNSHAAIDWG	SUPT6H	1661	Q7KZ85
SGQSSRNDWQVLQPE	SIRPB2	31	Q5JXA9
SQNDPNWVVRHQGKE	THBS1	971	P07996
NWRFDNTGDQHQIPQ	ZNF77	86	Q15935
WDQETHLRGNNFSGQ	ZSCAN31	21	Q96LW9
QSSHQRPGEQSEAWL	ZSCAN32	166	Q9NX65
NPAGTENNSIWELIH	TIAM2	1406	Q8IVF5
RHNWSGLDKQSDIQN	MIOS	471	Q9NXC5
WQENSEQGRREGHAQ	TNFAIP3	356	P21580
PQPNNSDWIQGHTRK	REV3L	1791	O60673
QDQRPDQELTGSWGH	SPHK2	11	Q9NRA0
NTLHLSNEQERGDWP	TMEM94	476	Q12767
LNNHMWNQRGSQAPE	TICAM1	691	Q8IUC6
WDNRDNSSQLQPGSH	ZNF646	1516	O15015
HQEVESPFQGRLQWN	SCN3B	81	Q9NY72
ETPEGTFWANNHGRN	PPP1R3F	266	Q6ZSY5
AFWVTNPNNTIRHNA	PKHD1L1	2561	Q86WI1
NNRWFNGQPIHAELS	U2AF1	131	Q01081
DDNHETDNNNPKRWS	TSHZ3	241	Q63HK5
SQAPEKQWHSQGLLQ	ZNF536	1226	O15090
NLQSWVREQHPESGE	ZKSCAN3	101	Q9BRR0
QSFQHQQDPSQIDWA	PNISR	21	Q8TF01
EPNNWLEGQQDSHLS	ZFP2	16	Q6ZN57
PAFTRQLASHQNIQW	USP34	2866	Q70CQ2
SQQNGHQVWEPEEDS	RPTN	641	Q6XPR3
VRDWLDASQQPGHQD	TRIM8	521	Q9BZR9
SHWNQNLGIINEDPG	TRPV4	786	Q9HBA0
EWNKLPSNQHSNDSA	TNRC6A	616	Q8NDV7
TQEEWGQLAPAHQNL	ZFP69	86	Q49AA0
QQNPHSWESWQTLGR	TTC33	121	Q6PID6
THQGQSPRNSWDRGT	ZNF641	421	Q96N77
WNSDTQNPYHQQALA	GEMIN4	276	P57678
DTHQAPAQALNETQW	LAMC3	1496	Q9Y6N6
NVNQQDNEGWTPLHA	PPP1R12B	116	O60237